On Monday, January 22, 2018, IFEZ entered into an investment agreement with Merck, a German technology and technology company, in the field of life sciences. Merck will establish 'Merck Korea Life Science Operation Headquarters (KRW 22.1 billion)' in Songdo, which will manufacture and supply cell culture media and provide related services.